AMPK activator 991

CAS No. 1219739-95-3

AMPK activator 991 ( —— )

Catalog No. M10830 CAS No. 1219739-95-3

AMPK activator 991 is an allosteric AMPK activator.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 1053 Get Quote
50MG 2142 Get Quote
100MG 2790 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    AMPK activator 991
  • Note
    Research use only, not for human use.
  • Brief Description
    AMPK activator 991 is an allosteric AMPK activator.
  • Description
    AMPK activator 991 is an allosteric AMPK activator, activates non-phosphorylated Thr172 AMPK in vitro binds to α1β1γ1 and α2β1γ1 with Kd of 0.13 and 0.17 uM, respectively.
  • Synonyms
    ——
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    AMPK
  • Recptor
    AMPK
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1219739-95-3
  • Formula Weight
    431.88
  • Molecular Formula
    C24H18ClN3O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC1=C(C=C(C=C1)OC2=NC3=C(N2)C=C(C(=C3)C4=CC5=C(C=C4)C=CN5C)Cl)C(=O)O
  • Chemical Name
    5-((5-chloro-6-(1-methyl-1H-indol-6-yl)-1H-benzo[d]imidazol-2-yl)oxy)-2-methylbenzoic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Willows R, et al. Biochem J. 2017 Aug 22;474(17):3059-3073.
2. Ngoei KRW, et al. Cell Chem Biol. 2018 Jun 21;25(6):728-737.e9.
molnova catalog
related products
  • MT47-100

    A novel potent, allosteric, simultaneously direct activator and inhibitor of AMPK complexes containing the β1 or β2 isoform, respectively.

  • Brazilin

    Brazilin has cancer preventive effect, may inhibit T24 cell growth and trigger cell death through a c-Fos-mediated and tumor cell specific signaling pathway.

  • Gomisin J

    Gomisin J is a natural product and have vasodilatory activity.?Gomisin J suppresses lipid accumulation by regulating the expression of lipogenic and lipolytic enzymes and inflammatory molecules through activation of AMPK, LKB1 and Ca2+/calmodulin-dependent protein kinase II and inhibition of fetuin-A in HepG2 cells.